A phase II study of high-dose octreotide in patients with unresectable pancreatic carcinoma

Author: Sulkowski U.   Buchler M.   Pederzoli P.   Arnold R.   Dinse P.   Kay A.   Haus U.   Beger H.G.  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.35, Iss.13, 1999-12, pp. : 1805-1808

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content